M.-F. Li

机构：Shanghai Jiao Tong University, Ruijin Hospital, World Wide Web Consortium, Shanghai Institute of Hypertension, National Center for Nanoscience and Technology · ORCID：0009-0003-0315-2464

发表论文 7 篇 · 总被引 274 次 · h-index 3

代表论文

• Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer (2010 · Carcinogenesis · 被引 247)
• SM22α-Lineage Perivascular Stromal Cells Contribute to Abdominal Aortic Aneurysm (2025 · Circulation Research · 被引 16)
• Personalized 3D Vaccine Integrates Immunotherapy and Antiangiogenic Therapy to Prevent Oral Squamous Cell Carcinoma Recurrence (2025 · Advanced Materials · 被引 7)
• Targeting IL-16 to Protect Angiotensin II–induced Hypertension and Renal Injury (2025 · Hypertension · 被引 3)
• 761 MACC1 PROTEIN: A PROMISING IMMUNOMARKER FOR THE DETECTION OF EARLY STAGE AND AFP NORMAL HEPATOCELLULAR CARCINOMAS (2012 · Journal of Hepatology · 被引 1)
• 325 HEPATITIS B VIRUS X GENE-UPREGULATED GENE 4 INDUCES CELL PROLIFERATION AND PROMOTES TUMORIGENICITY IN HUMAN HEPATOCELLULAR CARCINOMA THROUGH DOWNREGULATION OF FOXO3A (2012 · Journal of Hepatology)